At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

Clinical Review for Basic Researchers: Treating patients with CTLA‐4 and PD‐1 pathway blocking antibodies, plus clinical progress and application of agents in earlier stages of development. It is increasingly appreciated that cancers are recognized by the immune system, and under some circumstances,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of leukocyte biology Jg. 94; H. 1; S. 41 - 53
Hauptverfasser:	Callahan, Margaret K., Wolchok, Jedd D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Society for Leukocyte Biology 01.07.2013
Schlagworte:	Antibodies, Blocking - therapeutic use Clinical Trials as Topic CTLA-4 Antigen - antagonists & inhibitors CTLA-4 Antigen - immunology endpoints Humans Immunotherapy Neoplasms - immunology Neoplasms - therapy overall survival Paired Basic-Translational Reviews Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology tumor overall survival endpoints tumor
ISSN:	0741-5400, 1938-3673, 1938-3673
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!